Search Results 211-220 of 15166 for TNF
Currently receiving other interleukin (IL)-1 or IL-6 blockers, janus-activating kinase (JAK) or tumor necrosis factor (TNF) inhibitors. Has a history of ...
Selective IgA deficiency; Transient hypoagammaglobulinemia of infancy; Tumor necrosis factor receptor associated periodic syndrome (TRAPS); Wiskott-Aldrich ...
methotrexate [MTX]), immunomodulators, and/or tumor necrosis factor alpha (TNF-?) antagonist therapy (eg, infliximab, adalimumab). This includes ...
... tumor necrosis factor [anti-TNF] agents) within 2 weeks prior to randomization. Patients who have received acute, low-dose (≤ 10 mg oral prednisone or ...
Any medical condition requiring, or likely to require, chronic systemic corticosteroids, tumor necrosis factor (TNF) antagonists, or other immunosuppressant ...
The objective of our research is to determine whether inhibition of the tumor necrosis factor- alpha (TNF-a) pathway by Pentoxifylline reduces inflammatory ...
And in patients who don't respond to methotrexate, some people use the TNF blockers that are also used for rheumatoid arthritis. “ To have a place like this ...
Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...
... tumor necrosis factor-alpha [TNF-α] monoclonal antibody), immunosuppressants, low-dose steroids, or 5-aminosalicylic acid (5-ASA) formulations. Subjects who ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.